CYXO.ST
Price:
$0.018
Market Cap:
$6.75M
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
Industry
Biotechnology
IPO Date
2016-06-07
Stock Exchange
STO
Ticker
CYXO.ST
According to Cyxone AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 4.01. This represents a change of 42.06% compared to the average of 2.82 of the last 4 quarters.
The mean historical Current Ratio of Cyxone AB (publ) over the last ten years is 10.13. The current 4.01 Current Ratio has changed 3.86% with respect to the historical average. Over the past ten years (40 quarters), CYXO.ST's Current Ratio was at its highest in in the March 2017 quarter at 52.18. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
10.13
Median
7.67
Minimum
0.15
Maximum
30.07
Discovering the peaks and valleys of Cyxone AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.95%
Maximum Annual Current Ratio = 30.07
Minimum Annual Increase = -71.68%
Minimum Annual Current Ratio = 0.15
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 4.01 | -35.91% |
| 2022 | 6.26 | 34.21% |
| 2021 | 4.66 | -58.92% |
| 2020 | 11.35 | -38.58% |
| 2019 | 18.48 | 140.98% |
| 2018 | 7.67 | -9.98% |
| 2017 | 8.52 | -71.68% |
| 2016 | 30.07 | 19.95% |
The current Current Ratio of Cyxone AB (publ) (CYXO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.98
5-year avg
8.95
10-year avg
10.13
Cyxone AB (publ)’s Current Ratio is greater than Ziccum AB (publ) (0.36), greater than Bonzun AB (publ) (0.45), less than Redwood Pharma AB (5.39), greater than Cline Scientific AB (publ) (1.91), greater than Scandion Oncology A/S (1.81), greater than Asarina Pharma AB (publ) (1.20), greater than Hemcheck Sweden AB (publ) (3.42), greater than Idogen AB (publ) (1.67), greater than Duearity AB (publ) (0.88), less than Pharmiva AB (publ) (5.46),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.36 | $8.56M | |
| 0.45 | $7.25M | |
| 5.39 | $3.15M | |
| 1.91 | $3.11M | |
| 1.81 | $962.52K | |
| 1.20 | $633.96K | |
| 3.42 | $8.63M | |
| 1.67 | $12.79M | |
| 0.88 | $3.08M | |
| 5.46 | $12.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyxone AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyxone AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cyxone AB (publ)'s Current Ratio?
How is the Current Ratio calculated for Cyxone AB (publ) (CYXO.ST)?
What is the highest Current Ratio for Cyxone AB (publ) (CYXO.ST)?
What is the 3-year average Current Ratio for Cyxone AB (publ) (CYXO.ST)?
What is the 5-year average Current Ratio for Cyxone AB (publ) (CYXO.ST)?
How does the current Current Ratio for Cyxone AB (publ) (CYXO.ST) compare to its historical average?